Table 2.

Neurotensin receptor 1 expression n (%)

	Negative	1+	2+	3+
SAP	0	4 (23.53)	8 (47.06)	5 (29.41)
DALM	0	7 (41.42)	7 (41.42)	3 (17.65)
SCRC	0	0	1 (8.33)	11 (91.67)
CACRC	0	1 (7.69)	4 (30.77)	8 (61.54)

Comparison between colitis-associated dysplasia/carcinoma and sporadic dysplasia/carcinoma. Sporadic colorectal adenomatous polyp (SCRC) vs colitis-associated colorectal carcinoma (CACRC), P = 0.198; Dysplasia-associated lesions or masses (DALMs) vs CACRC, P = 0.028; DALMs vs sporadic colorectal carcinomas (SAPs), P = 0.50.